How to buy Abbott Laboratories stock (ABT)

Abbott Laboratories is a medical devices business based in the US. Abbott Laboratories shares (ABT) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $130.82 – an increase of 3.55% over the previous week. Abbott Laboratories employs 114,000 staff and has a trailing 12-month revenue of around $41.9 billion.

Our top picks for where to buy Abbott Laboratories stock

Buy Abbott Laboratories stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Abbott Laboratories stock price (NYSE: ABT)

Use our graph to track the performance of ABT stocks over time.

Abbott Laboratories shares at a glance

• Key figures

Information last updated 2025-03-27.

Latest market close	$130.82
52-week range	$98.72 - $141.23
50-day moving average more info button	$129.32
200-day moving average more info button	$116.29
Wall St. target price	$136.68
PE ratio more info button	17.1924
Dividend yield more info button	$2.24 (1.8%)
Earnings per share (TTM) more info button	$7.64

Is it a good time to buy Abbott Laboratories stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Abbott Laboratories price performance over time

Historical closes compared with the close of $131.35 from 2025-03-27

1 week (2025-03-21)	3.97%
1 month (2025-02-28)	-4.83%
3 months (2024-12-27)	14.23%
6 months (2024-09-27)	16.83%

1 year (2024-03-28)	15.56%
2 years (2023-03-29)	38.67%
3 years (2022-03-29)	15.81%
5 years (2020-03-27)	92.42%

Is Abbott Laboratories stock undervalued or overvalued?

Valuing Abbott Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Abbott Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Abbott Laboratories's P/E ratio

Abbott Laboratories's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, Abbott Laboratories shares trade at around 17x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Abbott Laboratories's PEG ratio

Abbott Laboratories's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.1675. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Abbott Laboratories's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Abbott Laboratories's EBITDA

Abbott Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $10.7 billion.

The EBITDA is a measure of a Abbott Laboratories's overall financial performance and is widely used to measure a its profitability.

Abbott Laboratories financials

Revenue TTM	$41.9 billion
Operating margin TTM	18.59%
Gross profit TTM	$23.3 billion
Return on assets TTM	6.06%
Return on equity TTM	30.91%
Profit margin	31.95%
Book value	$27.52
Market Capitalization more info button	$227.8 billion

TTM: trailing 12 months

Abbott Laboratories share dividends

Dividend payout ratio: 48.82% of net profits

Recently Abbott Laboratories has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Abbott Laboratories shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Abbott Laboratories's case, that would currently equate to about $2.24 per share.

While Abbott Laboratories's payout ratio might seem fairly standard, it's worth remembering that Abbott Laboratories may be investing much of the rest of its net profits in future growth.

Abbott Laboratories's most recent dividend payout was on 14 May 2025. The latest dividend was paid out to all shareholders who bought their shares by 14 April 2025 (the "ex-dividend date").

Have Abbott Laboratories's shares ever split?

Abbott Laboratories's shares were split on a 10000:4798 basis on 1 January 2013 . So if you had owned 4798 shares the day before before the split, the next day you'd have owned 10000 shares. This wouldn't directly have changed the overall worth of your Abbott Laboratories shares – just the quantity. However, indirectly, the new 52% lower share price could have impacted the market appetite for Abbott Laboratories shares which in turn could have impacted Abbott Laboratories's share price.

Abbott Laboratories share price volatility

Over the last 12 months, Abbott Laboratories's shares have ranged in value from as little as $98.7197 up to $141.23. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Abbott Laboratories's is 0.693. This would suggest that Abbott Laboratories's shares are less volatile than average (for this exchange).

Abbott Laboratories overview

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company provides pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. .

Frequently asked questions

null
What percentage of Abbott Laboratories is owned by insiders or institutions?
Currently 0.544% of Abbott Laboratories shares are held by insiders and 79.444% by institutions. How many people work for Abbott Laboratories?
Latest data suggests 114,000 work at Abbott Laboratories. When does the fiscal year end for Abbott Laboratories?
Abbott Laboratories's fiscal year ends in December. Where is Abbott Laboratories based?
Abbott Laboratories's address is: 100 Abbott Park Road, North Chicago, IL, United States, 60064-6400 What is Abbott Laboratories's ISIN number?
Abbott Laboratories's international securities identification number is: US0028241000 What is Abbott Laboratories's CUSIP number?
Abbott Laboratories's Committee on Uniform Securities Identification Procedures number is: 002824100